Atlas Trials

Bendamustine Hydrochloride in Treating Patients With Previously Treated Multiple Myeloma

Clinical trial NCT02315157 · WITHDRAWN

Trial details

NCT number
NCT02315157
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple MyelomaPlasma Cell Leukemia
Start date
2014-06-01
Primary completion
2018-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.